Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02905240 · ClinicalTrials.gov registry record · NA
Saline-Controlled Study of nSTRIDE APS for Knee Osteoarthritis
A NA study, sponsored by Zimmer Biomet.
- Completed
- Registry status
- NA
- Development phase
- 332
- Enrollment target
NCT02905240 is a NA study that has completed, run by Zimmer Biomet. The registered enrollment target is 332 participants.
The verdict
NCT02905240, a NA study, has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- NA
- Development phase
- 332 participants
- Enrollment target
Study Summary
A double-blind, multicenter, randomized, controlled trial (RCT) that will evaluate the efficacy of a single dose of Autologous Protein Solution (APS) in patients with Osteoarthritis (OA) of the knee.
Interventions
- DEVICE Saline
- DEVICE nSTRIDE APS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2016-11 |
| Est. Completion | 2020-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02905240
The ClinicalTrials.gov registry entry for NCT02905240 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 332 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT02905240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02905240 about?
NCT02905240 is a clinical study titled "Saline-Controlled Study of nSTRIDE APS for Knee Osteoarthritis". A double-blind, multicenter, randomized, controlled trial (RCT) that will evaluate the efficacy of a single dose of Autologous Protein Solution (APS) in patients with Osteoarthritis (OA) of the knee.
What is the current status of trial NCT02905240?
This trial is currently completed. It is a NA study. The enrollment target is 332 participants. The study started on 2016-11. Estimated completion is 2020-06.
What interventions are being tested in trial NCT02905240?
The interventions under investigation include: Saline (DEVICE), nSTRIDE APS (DEVICE).
Who is sponsoring clinical trial NCT02905240?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.